WANG Canlin,WANG Han,QIN Suyang,et al.Latent pathogen theory-guided differentiation and treatment strategies of postoperative recurrence of non-muscle-invasive bladder cancer[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(04):520-524.
WANG Canlin,WANG Han,QIN Suyang,et al.Latent pathogen theory-guided differentiation and treatment strategies of postoperative recurrence of non-muscle-invasive bladder cancer[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(04):520-524.DOI: 10.16025/j.1674-1307.2026.04.019.
Latent pathogen theory-guided differentiation and treatment strategies of postoperative recurrence of non-muscle-invasive bladder cancer
Postoperative recurrence of non-muscle-invasive bladder cancer is a major challenge and research focus in urology of integrated traditional Chinese and Western medicine. The traditional Chinese medicine (TCM) theory of "latent pathogen" is highly correlated with tumor recurrence. From the perspectives of the kidney, bladder, spleen-triple energizer and pleurodiaphragmatic interspace, and pathological factors including dampness-heat, phlegm, and blood stasis, therapeutic strategies may include clearing heat and removing toxin, dispersing and draining pathogens through multiple pathways, penetrating and regulating the pleurodiaphragmatic interspace, strengthening healthy
qi
and reinforcing the body resistance, and penetrating pathogens and dredging the collaterals. In addition, herb pairs such as
, which have shown remarkable efficacy in the treatment of bladder cancer, may provide new insights into the postoperative treatment of bladder cancer.
关键词
Keywords
references
LIN YC , CHU CY , HSIEH TH , et al . FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer [J ] . Cell Death Dis , 2025 , 16 ( 1 ): 485 .
BABJUK M , BURGER M , CAPOUN O , et al . European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ) [J ] . Eur Urol , 2022 , 81 ( 1 ): 75 - 94 .
BASU S , DONG Y , KUMAR R , et al . Slow-cycling(dor⁃ mant)cancer cells in therapy resistance,cancer relapse and metastasis [J ] . Semin Cancer Biol , 2022 , 78 : 90103 .